Heterozygosity testing and multiplex DNA panel screening as a potential tool to monitor health and inbreeding in a small, closed dog population

Abstract Background Selective breeding in populations with a limited effective population size may result in a loss of genetic diversity, which can cause an increased concentration of specific disease liability genes. The Dutch Shepherd Dog (DSD) in the Netherlands is an example of such a breed with a small effective population. Objective To evaluate the measurement of genetic diversity and multiplex DNA panel screening for implementation in a breeding strategy for the Dutch Shepherd Dog (DSD) and to investigate the clinical relevance of potentially identified mutations in the multiplex DNA pa... Mehr ...

Verfasser: S. F. A. Keijser
H. Fieten
M. Vos-Loohuis
C. J. Piek
H. Anderson
J. Donner
I. Scholten
M. Nielen
J. W. Hesselink
F. G. van Steenbeek
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: Canine Genetics and Epidemiology, Vol 5, Iss 1, Pp 1-9 (2018)
Verlag/Hrsg.: BMC
Schlagwörter: Canine health / Heterozygosity / Genetic disorder / Dog breeding / MyDogDNA™ / Dutch shepherd dog / Genetics / QH426-470 / Zoology / QL1-991
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26628000
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1186/s40575-018-0068-6

Abstract Background Selective breeding in populations with a limited effective population size may result in a loss of genetic diversity, which can cause an increased concentration of specific disease liability genes. The Dutch Shepherd Dog (DSD) in the Netherlands is an example of such a breed with a small effective population. Objective To evaluate the measurement of genetic diversity and multiplex DNA panel screening for implementation in a breeding strategy for the Dutch Shepherd Dog (DSD) and to investigate the clinical relevance of potentially identified mutations in the multiplex DNA panel screening. Results Genome-wide SNP testing showed genetic isolation and reduced genetic diversity within coat variety subgroups of the DSD. Panel screening identified a Von Willebrand’s Disease type I mutation. Although decreased Von Willebrand’s Factor proteins were significantly lower in DSDs carrying the VWD-I allele compared to the wildtype, clinical follow-up did not show a significant association between the clinical phenotype and VWD-I genotype. Conclusions Genetic relationship measurement within a breed population may be a useful tool to enable breeding strategies to conserve genetic diversity. Results from a disease panel screening need to be evaluated for clinical relevance before breed selection restrictions can be considered.